Carmignac Gestion’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-4,059
| Closed | -$2.09M | – | 140 |
|
2021
Q2 | $2.09M | Sell |
4,059
-30,697
| -88% | -$15.8M | 0.02% | 111 |
|
2021
Q1 | $27.2M | Sell |
34,756
-16,673
| -32% | -$13M | 0.31% | 53 |
|
2020
Q4 | $28M | Sell |
51,429
-1,507
| -3% | -$821K | 0.29% | 54 |
|
2020
Q3 | $24.3M | Sell |
52,936
-4,429
| -8% | -$2.03M | 0.29% | 53 |
|
2020
Q2 | $35.3M | Buy |
57,365
+7,724
| +16% | +$4.75M | 0.49% | 43 |
|
2020
Q1 | $23.6M | Buy |
49,641
+24,403
| +97% | +$11.6M | 0.4% | 46 |
|
2019
Q4 | $14.6M | Buy |
25,238
+14,823
| +142% | +$8.6M | 0.2% | 48 |
|
2019
Q3 | $6.85M | Sell |
10,415
-7,717
| -43% | -$5.08M | 0.09% | 67 |
|
2019
Q2 | $14M | Buy |
18,132
+6,077
| +50% | +$4.7M | 0.17% | 51 |
|
2019
Q1 | $8.51M | Buy |
12,055
+994
| +9% | +$702K | 0.1% | 66 |
|
2018
Q4 | $5.18M | Sell |
11,061
-2,844
| -20% | -$1.33M | 0.08% | 77 |
|
2018
Q3 | $12M | Sell |
13,905
-2,880
| -17% | -$2.48M | 0.1% | 67 |
|
2018
Q2 | $11.6M | Buy |
+16,785
| New | +$11.6M | 0.09% | 70 |
|